We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

155 hedge funds and large institutions have $201M invested in Immunogen Inc in 2016 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 57 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 23

2% less funds holding

Funds holding: 158 → 155 (-3)

21% less capital invested

Capital invested by funds: $254M → $201M (-$52.8M)

44% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 57

51% less call options, than puts

Call options by funds: $542K | Put options by funds: $1.1M

Holders
155
Holders Change
-3
Holders Change %
-1.9%
% of All Funds
4.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
32
Reduced
57
Closed
23
Calls
$542K
Puts
$1.1M
Net Calls
-$563K
Net Calls Change
-$1.4M

Top Buyers

Rank Fund Capital Flow
1
PAM
Panagora Asset Management
Massachusetts
+$1.75M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.56M
3
KBC Group
KBC Group
Belgium
+$635K
4
BFA
BlackRock Fund Advisors
California
+$579K
5
Millennium Management
Millennium Management
New York
+$552K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$4.54M
2
Morgan Stanley
Morgan Stanley
New York
-$3.94M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$3.26M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.99M
5
Macquarie Group
Macquarie Group
Australia
-$2.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
ClearBridge Investments
1
ClearBridge Investments
New York
$40.7M -$1.06M -365,094 -2%
Primecap Management
2
Primecap Management
California
$25.8M -$1.44M -494,507 -5%
O
3
OrbiMed
New York
$16.3M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$15.8M -$3.26M -1,121,389 -16%
BFA
5
BlackRock Fund Advisors
California
$8.87M +$579K +199,247 +6%
BBA
6
Baker Bros. Advisors
New York
$8.08M – – –
Renaissance Technologies
7
Renaissance Technologies
New York
$6.71M +$1.56M +536,200 +27%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$5.88M -$2.99M -1,026,583 -32%
BIT
9
BlackRock Institutional Trust
California
$5.7M +$65.2K +22,427 +1%
Millennium Management
10
Millennium Management
New York
$4.86M +$552K +189,812 +12%
PA
11
Pinnacle Associates
New York
$4.66M -$78.1K -26,870 -2%
Deutsche Bank
12
Deutsche Bank
Germany
$4.2M +$305K +104,752 +7%
Wells Fargo
13
Wells Fargo
California
$3.97M +$86.3K +29,673 +2%
State Street
14
State Street
Massachusetts
$3.97M -$4.54M -1,561,271 -51%
Norges Bank
15
Norges Bank
Norway
$3.92M – – –
Bank of America
16
Bank of America
North Carolina
$3.72M +$275K +94,729 +7%
Morgan Stanley
17
Morgan Stanley
New York
$3.03M -$3.94M -1,355,601 -55%
Northern Trust
18
Northern Trust
Illinois
$2.7M -$6.25K -2,150 -0.2%
Franklin Resources
19
Franklin Resources
California
$2.54M – – –
Macquarie Group
20
Macquarie Group
Australia
$2.49M -$2.7M -930,000 -50%
PAM
21
Panagora Asset Management
Massachusetts
$2.25M +$1.75M +602,649 +253%
RJA
22
Raymond James & Associates
Florida
$1.76M +$31.3K +10,762 +2%
Goldman Sachs
23
Goldman Sachs
New York
$1.73M +$344K +118,132 +22%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$1.71M +$53.6K +18,448 +3%
Charles Schwab
25
Charles Schwab
California
$1.04M +$255K +87,648 +29%
1
2 3 4 5

IMGN Hedge Fund Activity: Q3 2016 in Review

155 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2016, worth a combined $201M — down 21% from $254M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of IMGN and 22 opened new positions — a net loss of 1 holder — while 57 trimmed existing stakes and 32 added.

The largest buyer was Panagora Asset Management, adding an estimated $1.75M. The largest seller was State Street, cutting an estimated $4.54M.

  • 155 institutional investors held Immunogen Inc (IMGN) as of Q3 2016, down from 158 in Q2 2016.
  • Funds reported $201M of Immunogen Inc stock for Q3 2016, down 21% quarter-over-quarter.
  • 22 funds opened new Immunogen Inc positions in Q3 2016 and 23 closed out, a net change of -1 holder.
  • The largest Immunogen Inc buyer in Q3 2016 was Panagora Asset Management, an estimated $1.75M added.
  • The largest Immunogen Inc seller in Q3 2016 was State Street, an estimated $4.54M sold.

Based on aggregated 13F filings for Q3 2016.